From Microbes to Degradation: Developing a b-catenin Degrader – From Bacteria to in-vivo

• Sharing Coltac’s pre-clinical data, degrading b-catenin for CRC
• Leveraging bacteria for the discovery of MG
• What’s next in MG discovery and development

Speakers:

Yaron Sfadyah

Chief Executive Officer

Coltac Therapeutics